Last Funding Type: Series B
Funding Status: Early Stage Venture
Headquarters: Seattle, Washington, United States
Founded Date: 2008-01-01
Last Funding Date: 2022-03-29
Total Funding: 51447828.0
Technology: Biotechnology, Information Services, Information Technology, Manufacturing
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Investors Number: 13.0
Industry: Early Drug Development